Benefits
- High-quality, well-characterized pluripotent stem cells
- Robust expansion capacity for large-scale experiments
- Retain full differentiation potential into ectoderm, mesoderm, and endoderm lineages
- Suitable for genome editing, disease modeling, and cell-based therapy research
Product Specifications
|
Feature |
Detail |
|---|---|
|
Identity Markers |
≥ 90% expression of pluripotency markers (e.g. OCT4, SOX2, NANOG, TRA-1-60, SSEA4) by immunostaining and flow cytometry; absence of differentiation markers |
|
Quantities |
≥ 1 × 10⁶ and ≥ 5 × 10⁶ viable cells |
|
Quality Control |
Cell count, viability, pluripotency marker expression (FACS), karyotype stability, mycoplasma testing |
|
Format |
Cryopreserved, ready-to-thaw vials |
|
Donor & Reprogramming |
Specified donor (healthy/diseased background available); Sendai Virus or non-integrating episomal reprogramming |
|
Shipping / Storage |
Shipped in dry shippers at -180°C to -135°C; store in vapor phase of liquid nitrogen |
|
Supplied with |
Pluripotent stem cell culture medium, user guide with instructions for thawing, passaging, and maintenance |
Technical Data
- High viability and robust colony morphology upon thawing
- Maintains stable karyotype over multiple passages
- Differentiates efficiently into ectodermal (neurons), mesodermal (cardiomyocytes, endothelial cells), and endodermal (hepatocytes, pancreatic cells) lineages
- Compatible with CRISPR/Cas9-based genome editing
Explore iPSC -Academia
Discover our high-purity, iPSC-derived ventricular cardiomyocytes designed for cardiac safety, electrophysiology, and drug discovery research. Check out the product details to see how these cells can accelerate your studies.